AIHTA - Publications - Search - Cabozantinib (Cabometyx®) as monotherapy for the treatment of locally advanced or metastatic differentiated thyroid carcinoma (DTC)

Rothschedl, E. and Wolf, S. (2022): Cabozantinib (Cabometyx®) as monotherapy for the treatment of locally advanced or metastatic differentiated thyroid carcinoma (DTC). Oncology Fact Sheet Nr. 87.

[thumbnail of Oncology Fact Sheet Nr.87.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
83kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WK Endocrine system > WK 200-300 Thyroid gland. Parathyroid gland
Language:English
Series Name:Oncology Fact Sheet Nr. 87
Deposited on:25 Apr 2022 14:30
Last Modified:16 May 2022 09:31

Repository Staff Only: item control page